Class Action Lawsuit Filed Against Immutep Limited (NASDAQ: IMMP) Over Alleged Securities Fraud
A class action lawsuit has been filed against Immutep Limited (IMMP), alleging securities fraud and unlawful business practices. The firm Pomerantz LLP is representing investors who suffered losses during the specified Class Period, with a deadline of July 6, 2026 to appoint a lead plaintiff.

Tickers: $IMMP
Topics: clinical trial discontinuation securities fraud stock price drop